Jefferies Reiterates Buy Rating on Moderna (MRNA)

September 12, 2024 8:07 AM UTC Send to a Friend
Jefferies analyst Michael Yee reiterated a Buy rating and $120.00 price target on Moderna (NASDAQ: MRNA).The analyst comments "Ahead of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login